Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Januar 2025 08:00 ET | Quelle: Cargo Therapeutics, Inc.

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
12. November 2024 16:05 ET | Quelle: Cargo Therapeutics, Inc.

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
10. Juli 2024 08:00 ET | Quelle: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
28. Mai 2024 08:05 ET | Quelle: Cargo Therapeutics, Inc.

CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics to Participate in Upcoming Investor Conferences
09. November 2023 20:07 ET | Quelle: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces Pricing of Initial Public Offering

CARGO Therapeutics Announce Pricing of IPO
02. März 2021 09:00 ET | Quelle: Sorrento Therapeutics, Inc.

Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple Malignancies

Internally developed fully human anti-CD47 antibody (STI-6643) cleared for basket trial;No complicated titration or priming dose of the antibody is required to reduce toxicity;This study will be...